Interstitial photodynamic therapy: diagnostic measurements and treatment in experimental malignant rat tumors

A recently developed multiple fiber system for treating malignant tumors with interstitial photodynamic therapy was used in studies on rats with colon adenocarcinoma inoculated into the muscles of the hind legs. The animals were intraperitonially administrated (delta) -aminolevulinic acid (ALA), which is metabolized to protoporphyrin IX (PpIX) in the tissue. The treatment system consists of a laser light source, a beam-splitting system dividing the light into three or six output fibers and a dosimetry program calculating the optimal fiber position within the tumor as well as the treatment time needed to obtain a given threshold value of the light dose. One aim of the study was to compare the treatment outcome with the modelled dosimetry predictions. Tumor reduction was examined three days post treatment. A volume decrease was found in 85% of the treated tumors. The mean volume reduction was 44%, with one tumor completely disappearing. Histopathological examination three days post treatment showed substantial necrotic parts which, however, to a smaller extent were present also for non-treated tumors. These results indicated that the tumors have been under treated and the light dose has to be increased. Measurements of the build-up and photo-induced bleaching of PpIX using laser-induced fluorescence were also performed during the experiments.

[1]  CLAUDE C. FRAZIER,et al.  PHOTODYNAMIC THERAPY IN DERMATOLOGY , 1996, International journal of dermatology.

[2]  R. E. Thoma,et al.  Interstitial photoradiation therapy for primary solid tumors in pet cats and dogs. , 1981, Cancer research.

[3]  Annika Enejder,et al.  Photodynamic therapy versus cryosurgery of basal cell carcinomas; results of a phase III randomized clinical trial , 1999 .

[4]  N. Bendsøe,et al.  Photodynamic therapy and diagnostic measurements of basal cell carcinomas using esterified and non-esterified delta-aminolevulinic acid , 2001 .

[5]  K. Svanberg,et al.  Laser‐induced fluorescence studies of normal and malignant tumour tissue of rat following intravenous injection of δ‐amino levulinic acid , 1997, Lasers in surgery and medicine.

[6]  W. Star,et al.  Tumor and normal tissue response to interstitial photodynamic therapy of the rat R-1 rhabdomyosarcoma. , 1992, International journal of radiation oncology, biology, physics.

[7]  I. Driver,et al.  Interstitial photodynamic therapy. Clinical experience with diffusing fibres in the treatment of cutaneous and subcutaneous tumours. , 1993, British Journal of Cancer.

[8]  P Baas,et al.  What does photodynamic therapy have to offer radiation oncologists (or their cancer patients)? , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  W. Star,et al.  In vivo fluorescence kinetics and photodynamic therapy using 5-aminolaevulinic acid-induced porphyrin: increased damage after multiple irradiations. , 1994, British Journal of Cancer.

[10]  K Svanberg,et al.  Photodynamic therapy of non‐melanoma malignant tumours of the skin using topical δ‐amino levulinic acid sensitization and laser irradiation , 1994, The British journal of dermatology.

[11]  G. Jori,et al.  Tumour photosensitizers: approaches to enhance the selectivity and efficiency of photodynamic therapy. , 1996, Journal of photochemistry and photobiology. B, Biology.